Description
A novel triple-receptor agonist designed to act on GLP-1, GIP, and glucagon pathways, currently undergoing late-stage clinical evaluation for obesity and metabolic conditions. It is being researched for its strong potential to influence appetite control, improve insulin responsiveness, and support healthy lipid metabolism
Strictly for Research Use Only
Refrigerate after reconstitution














Reviews
There are no reviews yet.